Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators

Molecular Endocrinology

Volumn 14, Issue 12, 2000, Pages 1962-1975

  Lazennec, Gwendal ^a   Canaple, Laurence ^a,b   Saugy, Damien ^b   Wahli, Walter ^b  

^a INSERM   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME ACTIVATOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; RECEPTOR SUBTYPE; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; EXERCISE; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; STRESS;

ANIMALIA;

EID: 0034530972     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.12.0575     Document Type: Article

References (58)

1. A unified nomenclature system for the nuclear receptor superfamily
2. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
3. Steroid hormone receptors: Many actors in search of a plot
4. The nuclear receptor superfamily: The second decade
5. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
6. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
7. The chicken oestrogen receptor sequence: Homology with v-erbA and the human oestrogen and glucocorticoid receptors
8. Peroxisome proliferator-activated receptors, orphans with ligands and functions
9. Characterization of the amino-terminal activation domain of peroxisome proliferator-activated receptor α. Importance of α-helical structure in the transactivating function
10. The structure of the nuclear hormone receptors
11. Nuclear receptor coregulators: Cellular and molecular biology
12. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
13. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: Correlations with DNA and coregulator interactions and receptor conformational changes
14. The peroxisome proliferator-activated receptor α is a phosphoprotein: Regulation by insulin
15. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ
16. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
17. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase
18. Phosphorylation of peroxisome proliferator-activated receptor α in rat Fao cells and stimulation by ciprofibrate
19. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain
20. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-γ
21. Ligand-independent activation domain in the n terminus of peroxisome proliferatoractivated receptor γ (PPAR-γ)-differential activity of PPAR-γ-1 and -2 isoforms and influence of insulin
22. Control of fructose 2,6-diphosphate in muscle of exercising fasted rats
23. Role of cAMP in mediating effects of fasting on dephosphorylation of insulin receptor
24. Peroxisome proliferator-activated receptor α controls the hepatic CYP4A induction adaptive response to starvation and diabetes
25. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm
26. A critical role for the peroxisome proliferator-activated receptor alpha (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
27. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells
28. Phosphorylation of human estrogen receptor a by protein kinase A regulates dimerization
29. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding
30. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice resuits in abolishment of the pleiotropic effects of peroxisome proliferators
31. Responsiveness to · thyroid hormone is enhanced m rat hepatocytes cultured as spheroids compared with that in monolayers: Altered responsiveness to thyroid hormone possibly involves complex formed on thyroid hormone response elements
32. Interdomain communication regulating ligand binding by PPAR-γ
33. Modulation of glucocorticoid receptor function by protein kinase A
34. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
35. Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors
36. Synergistic enhancement of prb-mediated ru486 and r5020 agonist activities through cyclic adenosine 3′,5′-monophosphate represents a delayed primary response
37. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways
38. Mutations in the activation function-2 core domain of steroidogenic factor-1 dominantly suppresses PKA-dependent transactivation of the bovine cyp17 gene
39. Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4
40. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens
41. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: Antiestrogen selectivity and promoter dependence
42. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators
43. Characterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-γ: Evidence that the AF-1 region functions in a cell-specific manner
44. Phosphorylation of the retinoic acid receptor-α by protein kinase A
45. Phosphorylation of activation functions AF-1 and AF-2 of RARα and RARγ is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment
46. Two separate mechanisms for ligand-independent activation of the estrogen receptor
47. Modulation of human mineralocorticoid receptor function by protein kinase A
48. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver
49. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor a (PPAR-α)
50. Plasma cAMP: A hepatorenal link influencing proximal reabsorption and renal hemodynamics?
51. Mechanisms of catecholamine effects on ketogenesis
52. Peroxisome proliferator-activated receptor a mediates the adaptive response to fasting
53. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
54. The PPARα-leukotriene B4 pathway to inflammation control
55. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation
56. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element
57. Preparation of isolated rat liver cells